Invention Grant
- Patent Title: Variant of a BPIFB4 protein
-
Application No.: US17525531Application Date: 2021-11-12
-
Publication No.: US11891421B2Publication Date: 2024-02-06
- Inventor: Annibale Alessandro Puca , Carmine Vecchione
- Applicant: ROXIANT APS
- Applicant Address: DK Copenhagen
- Assignee: LGVI S.R.L.
- Current Assignee: LGVI S.R.L.
- Current Assignee Address: IT Naples
- Agency: Hoffmann & Baron, LLP
- Priority: EP 425208 2012.12.28
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C12N15/86 ; C12N15/85 ; C12N15/81
Abstract:
The present invention relates to a variant of BPIFB4 protein (Bactericidal/Permeability Increasing protein family B, member 4) and to a polynucleotide or a vector encoding said variant of BPIFB4 protein and to their use for the treatment of pathologies involving impairment of nitric oxide signalling.
Public/Granted literature
- US20220169686A1 VARIANT OF A BPIFB4 PROTEIN Public/Granted day:2022-06-02
Information query
